Healthcare provider profile · identity verified

Dean Morris, MD

Family Practice · BEDFORD, NH · NPI 1811943442

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	410	138
Levothyroxine Sodium	Levothyroxine Sodium	237	63
Lisinopril	Lisinopril	231	70
Amlodipine Besylate	Amlodipine Besylate	202	58
Simvastatin	Simvastatin	163	49
Sertraline Hcl	Sertraline Hcl	139	42
Metoprolol Succinate	Metoprolol Succinate	128	41
Hydrochlorothiazide	Hydrochlorothiazide	101	25
Metformin Hcl	Metformin Hcl	93	30
Losartan Potassium	Losartan Potassium	90	26
Omeprazole	Omeprazole	90	36
Rosuvastatin Calcium	Rosuvastatin Calcium	88	30
Pantoprazole Sodium	Pantoprazole Sodium	79	28
Albuterol Sulfate Hfa	Albuterol Sulfate	70	29
Metoprolol Tartrate	Metoprolol Tartrate	61	18
Famotidine	Famotidine	56	19
Allopurinol	Allopurinol	54	18
Furosemide	Furosemide	52	15
Zolpidem Tartrate	Zolpidem Tartrate	51	11
Warfarin Sodium	Warfarin Sodium	49	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	48	18
Eliquis	Apixaban	46	suppressed
Gabapentin	Gabapentin	46	14
Metformin Hcl Er	Metformin Hcl	43	18
Pravastatin Sodium	Pravastatin Sodium	43	14
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Bupropion Xl	Bupropion Hcl	41	11
Glipizide Er	Glipizide	40	14
Atenolol	Atenolol	37	12
Fluticasone Propionate	Fluticasone Propionate	37	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	12
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Montelukast Sodium	Montelukast Sodium	29	11
Synthroid	Levothyroxine Sodium	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Nystatin	Nystatin	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Carvedilol	Carvedilol	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Ozempic	Semaglutide	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Zaleplon	Zaleplon	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error